ALLO
Allogene Therapeutics Inc
1.70$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 60.5% | 75.9% | 68.8% | 44.9% | 64.4% | 71.4% | 55.3% | 62.0% | |
| – | 93.2% | 24.4% | 14.9% | 16.5% | 7.5% | 12.9% | 13.7% | 12.4% | |
| – | 93.2% | 73.9% | 67.4% | 43.5% | 63.0% | 69.8% | 53.3% | 60.2% | |
| – | 0.4% | 0.3% | 0.2% | 0.6% | 0.4% | 0.3% | 0.3% | 0.4% | |
| – | -33.9% | -8.5% | -16.9% | -1.9% | -7.6% | -9.7% | – | – | |
| – | 5.4% | 14.1% | 9.7% | 11.7% | 23.9% | – | – | – | |
| – | 0.1% | 0.0% | – | – | – | – | – | – | |
| – | 9.1% | 12.4% | 12.1% | 12.0% | 18.8% | 20.3% | 23.1% | 29.7% | |
| – | 3.8% | 4.6% | 7.7% | 4.6% | 6.5% | 5.8% | 6.5% | 7.8% | |
| – | – | 0.2% | 0.2% | 0.3% | 0.7% | 1.1% | 1.4% | 2.0% | |
| – | 1.6% | 1.3% | 0.8% | 1.0% | 1.7% | 0.9% | 1.0% | 1.0% | |
| – | 4.5% | – | – | – | – | – | – | – | |
| – | 90.9% | 87.6% | 87.9% | 88.0% | 81.2% | 79.7% | 76.9% | 70.3% | |
| – | -27.3% | -55.2% | -52.6% | -85.1% | -150.3% | -243.0% | -331.7% | -483.5% | |
| – | 11.6% | 14.1% | 9.8% | 12.9% | 17.4% | 24.4% | 35.5% | 53.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.